Get started
Author

Amanda Nizam

Observed names: A. Nizam, Nizam, A., Nizam, Amanda
ORCID: 0000-0001-5181-490X
Observed ORCID: 0000-0001-5181-490X
OpenAlex ID: A5072435293
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
2021 · P. Grivas, A.R. Khaki, et al. · Annals of Oncology · 309
PDF
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
2021 · Michael A. Thompson, Jeffrey P. Henderson, et al. · JAMA Oncology · 192
PDF
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
2021 · Vadim S. Koshkin, Nicholas Henderson, et al. · Cancer · 88
PDF
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
2022 · Julie Fu, Sonya A. Reid, et al. · JAMA Network Open · 66
PDF
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54
PDF
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
2021 · Andrew L. Schmidt, Matthew D. Tucker, et al. · JAMA Network Open · 38
PDF
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
2020 · Maheen Abidi, David M. Aboulafia, et al. · Cancer Cell · 31
PDF
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
2022 · Arielle Elkrief, Cassandra Hennessy, et al. · The Lancet Healthy Longevity · 23
Outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV) after switch maintenance avelumab (MAv) in the UNITE study.
2024 · Amanda Nizam, Tanya Jindal, et al. · Journal of Clinical Oncology · 18
PDF
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
2022 · Samuel M. Rubinstein, Divaya Bhutani, et al. · Blood Cancer Discovery · 17
PDF
Outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma and histology variants: Analysis of the UNITE study.
2024 · Tanya Jindal, Cindy Y. Jiang, et al. · Journal of Clinical Oncology · 15
The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
2020 · Amanda Nizam, Jonah A. Schindelheim, et al. · Cancer Treatment and Research Communications · 13
PDF
Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
2025 · Amanda Nizam, Charles B. Nguyen, et al. · Cancer Medicine · 12
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
2023 · Amanda Nizam, Ryan K. Rader, et al. · Clinical Genitourinary Cancer · 12
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
2025 · Tanya Jindal, Cindy Y. Jiang, et al. · European Urology · 11
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
2024 · Tanya Jindal, Cindy Jiang, et al. · European Urology Oncology · 11
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
2023 · Shuchi Gulati, Chih-Yuan Hsu, et al. · JAMA Oncology · 10
PDF
Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
2023 · Tanya Jindal, Li Zhang, et al. · Journal of Clinical Oncology · 10
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
2022 · Jessica E. Hawley, Tianyi Sun, et al. · JAMA Network Open · 10
PDF
Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data
2019 · Jeanny B. Aragon-Ching, Amanda Nizam, et al. · Clinical Genitourinary Cancer · 10
Frontline immunotherapy treatment with nivolumab and ipilimumab in metastatic renal cell cancer: a new standard of care
2018 · Amanda Nizam, Jeanny B. Aragon-Ching · Cancer Biology & Therapy · 10
PDF
Epithelioid Angiosarcoma of the Bladder: A Case Report and Review of the Literature
2018 · Amanda Nizam, Edmond L. Paquette, et al. · Clinical Genitourinary Cancer · 10
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
2023 · Tanya Jindal, Deepak Kilari, et al. · Journal of Clinical Oncology · 7
PDF
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function
2024 · Eiftu S. Haile, Zaeem Lone, et al. · British Journal of Urology · 6
Biomarkers of response to sacituzumab govitecan (SG) and efficacy after treatment with enfortumab vedotin (EV) in advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
2023 · Tanya Jindal, Cindy Jiang, et al. · Journal of Clinical Oncology · 6
Works count: 109
Citation count: 1,059
H-index: 12
I10-index: 22
Year
Topic
Type